Philip Rosenthal
Pediatrics · San Francisco, CANPI 1417066242
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Mirum Pharmaceuticals, Inc. accounts for 63.6% of it on its own, with 11 other manufacturers making up the rest. Among pediatrics clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 84 payments — averaging $975.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mirum Pharmaceuticals, Inc.$52K
- Ipsen Biopharmaceuticals, Inc$16K
- Albireo Pharma, Inc.$5K
- Gilead$3K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Biomarin Pharmaceutical Inc.$2K
- plus $3K from 6 others
Across 224 payments — averaging $4940.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Albireo Pharma, Inc.$390K
- Gilead$347K
- Takeda Pharmaceuticals U.S.A., Inc.$242K
- AbbVie$60K
- Merck$47K
- Mirum Pharmaceuticals, Inc.$13K
- plus $8K from 1 others
What the payments were for
- Consulting fees$49,01160%
- Speaking & faculty fees$16,24520%
- Travel & lodging$14,62918%
- Food & beverage$2,0793%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mirum Pharmaceuticals, Inc. | 51 | $52,138 |
| Ipsen Biopharmaceuticals, Inc | 8 | $15,668 |
| Albireo Pharma, Inc. | 3 | $4,599 |
| Gilead | 2 | $2,744 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $2,159 |
| Biomarin Pharmaceutical Inc. | 1 | $1,800 |
| Vertex | 2 | $1,400 |
| Cepheid | 1 | $503 |
| ZOLL Medical Corporation | 1 | $358 |
| Intra-sana Laboratories | 1 | $250 |
| Sentynl Therapeutics, Inc. | 1 | $200 |
| Stryker | 1 | $145 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Livmarli$38,923
- Bylvay$20,109
- Vemlidy$2,710
- GENEXPERT$503
- Reltone 200 Mg$250
- Reltone 400 Mg$250
- VARIAX$145
How this compares
$81,964 in reported general payments places this provider in the 95th percentile of 5,539 pediatrics providers in California.
Other pediatrics in San Francisco
- Tonya ChaffeeSan Francisco$359K
- Anthony PortaleSan Francisco$354K
- David KesslerSan Francisco$335K
- Jonathan StroberSan Francisco$164K
- Anna MoscickiSan Francisco$88K
- Yvette WildSan Francisco$75K
- Ilona FriedenSan Francisco$62K
- Farzana PerwadSan Francisco$30K
- Melvin HeymanSan Francisco$25K
- Mary LeshSan Francisco$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.